Joerg Herrmann (@mayocvonc) profile picture

Mayo Clinic Cardiology Consultant, director of the cardio-oncology program @MayoClinic, tweets are my own

Minnesota, USA
Joined March 2016
Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)Photo by Joerg Herrmann (@mayocvonc)
Finally arrived! Deepest thanks to Dr. Braunwald, all the collaborators and the entire Elsevier team! #cardiooncology @MayoClinicCV
48
43
13
502
Joerg Herrmann retweeted
An inspiring evening at the British Ambassador’s Residence in Washington, DC bringing together clinicians, researchers, advocates and policymakers united by a shared mission: ensuring cardiovascular health is central to every stage of cancer care. Grateful to Sir Christian Turner and colleagues for hosting the Royal Brompton Hospital Cardio-Oncology reception, and proud to mark the forthcoming @TheLancet Group Cardio-Oncology Series ahead of #GCOS2026. As cancer survival improves, cardiotoxicity prevention, earlier detection and lifelong cardiovascular care must no longer be an afterthought, they must be built into cancer care by design. #CardioOncology #Cardiology #Oncology #globalhealth #healthcareinnovation
1
7
18
815
Joerg Herrmann retweeted
Fantastic session highlighting the role of AI in #cardioonc @ICOSociety
6
17
553
Thanks Dr @rc_oncneph and @ShrutiGkidney for the invitation! Outstanding meeting with great discussions ! @MayoClinicNeph @OncnephBoston26 @onconephsociety
Murine Models & Immune Therapy: What Can Mice Teach Us About AIN ? 🎙️ @HerrmannMd How do we understand ICI-AIN when kidney biopsies give us only a snapshot? Murine models let us track immune cells over time, dissect mechanisms and test potential therapies @rc_oncneph
12
36
1,891
Can #AI predict cardiotoxicity before symptoms appear? Join @mayocvonc and the rest of the panel at #GCOS26 to explore how #artficialintelligence is reshaping #cardiooncology care. 🎟️ Save your spot: tinyurl.com/2dx225jt #CardioOnc #AIinHealthcare #ClinicalAI
4
7
342
Joerg Herrmann retweeted
Behind the scenes from the Herrmann lab at the Mayo Clinic Rochester. From left to right: Luis E. Gutierrez, M.D.; Victor Cuenca Narvaez, M.D. @VictorCuenca3; Michele Barbarini, M.B.B.S. @MBarbarini; Pouneh Mirkheshti; and PI Sandra M. Herrmann, M.D. @HerrmannMd.
4
1
8
3,961
Joerg Herrmann retweeted
Over the last decade, immune #CheckpointInhibitors have revolutionized cancer therapy. However, they can cause immune-related adverse events, including acute kidney injury. doi.org/10.1172/jci.insight.… Using a humanized mouse model, Victor D. Cuenca Narvaez @VictorCuenca3, Michele Barbarini @MBarbarini, and Sandra M. Herrmann @HerrmannMd & team @MayoClinic now show that TNF‑α blockade reduces kidney inflammation caused by immune checkpoint inhibitors, suggesting a potential strategy to prevent immune‑related kidney injury. The image represents reduced TNF-α expression in the kidney tissue in the ICI-TNF-α-Blockade group (compared to ICI-Only and ICI-Cytokines). #Nephrology
1
10
18
1,552
Joerg Herrmann retweeted
Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are associated with immune-related complications that can affect the kidneys. A study led by Sandra Herrmann, M.D., an onconephrologist and researcher at Mayo Clinic, helps clarify how immune-related kidney inflammation develops and provides preclinical evidence supporting a targeted approach that could improve how these side effects are managed — and could potentially be prevented. Learn more: mayocl.in/3Omhmtk
9
10
1
25
4,538
OMG what an amazing way to start the 2nd day at #GCOS2023 !!! @mayocvonc and #DrAnaBlaes summarising the most relevant papers on cardio-onc and oncology published in 2023!! My favourite?? #STOP-CA 💊and BREXIT 🏃‍♀️trials
2
25
940
Sessions underway. Whats hot this past year in #cardioonc @BlaesAnneMD @mayocvonc @SverdlovAaron #GCOS2023
9
1
31
3,583
Joerg Herrmann retweeted
🚀📚 Exciting times in #CardioOnc! Dr. Hermann from @mayocvonc is showcasing the year's most pivotal cardio-oncology research at #GCOS2023. From childhood cancer late effects to groundbreaking clinical trials, the landscape is evolving rapidly. Dive in! 🌊 1/4
1
10
21
1,397
🎙️ Insightful conversation! @abdelcards from @mdandersonnews recently spoke with Dr. @mayocvonc of @MayoClinic. They delved into the future vision of cardio-oncology for the upcoming decade and tackled the challenges in research. Stay tuned for the highlights! 🌟
1
10
25
1,698
Nice to see this algorithm presented at @ERAkidney meeting @Daanvandorst @ninianlang @mayocvonc @Jorie_Vers 👇🏽 link bellow open access – at Minnesota, USA
3/ Before anticancer treatment, check: ✅ BP ✅CV risk factors, CVD history ✅ end-organ damage ✅ labs ✅ ECG& echo if cardiotoxic drugs 💔 🔗ncbi.nlm.nih.gov/pmc/article… #ERA23
2
6
1,060
Great to see our paper on #cancer therapy-associated hypertension Lloyd Butel-Simoes @TattJhong_Haw @Williams1Trent Shanathan Sritharan, Payal Gadre @HerrmannMd @mayocvonc @DoanNgo4 @ICOSociety @heartfoundation @HMRIAustralia @HNEHealth
REVIEW: Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation ahajournals.org/doi/10.1161/…
1
14
31
2,590
Outstanding faculty, experts and talks at Mayo Cardio-Oncology Update 2023 @MayoClinicCV #cardio-oncology – at Scottsdale, AZ
1
3
28
2,266
Joerg Herrmann retweeted
Great work to @MayoClinicCV @mayocvonc @DavidHolmes2 & team on this piece on #laao in #cardioonc (I wish this was me but this is my IC superior @yangrybadger on this :)) @DrRCChester @netta_doc @shivkumarmd @Dr_Mike_Fradley #epeeps
☂️ Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer @JACCJournals #CardioTwitter #CardioOnc #CardioEd
1
8
21
3,639
There’s still time to register for Cardio-Oncology Update 2023! @mayocvonc
Providers who care for patients with cancer, join us for Cardio-Oncology Update 2023! Our expert faculty will cover prevention, diagnosis, & management of cardiovascular diseases of patients with #cancer. April 27-29 in Arizona & via livestream: mayocl.in/412eCSZ
1
2
667